Dachaigh › Galar Depressive Mòr › Utah
Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Utah
Tha 15 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann an Utah.
Bailtean ann an Utah
- Salt Lake City4 sgrùdaidhean
- Ogden3 sgrùdaidhean
- Orem3 sgrùdaidhean
- Provo3 sgrùdaidhean
- Sandy3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
- Aura Wellness, Salt Lake City
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07284667A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Cedar Clinical Research, Draper
- Inner Space Research, Orem
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07412756A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07573176A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Boeson Research - Provo, Provo
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07775300A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Boeson Research Pvu, Provo
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07621237A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Boeson Research, Provo
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07076407Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Utah Hospital, Salt Lake City
A’ fastadh
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT064234305-HTP and Creatine for Depression R33 Phase
- University of Utah Department of Psychiatry, Salt Lake City
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Lùna 2026 · NCT05895747Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Andes Clinical Research, Orem
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Draper
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07196501A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Cedar Clinical Research Inc, Draper
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #159, Orem
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT06633016Mechanisms of Rumination Change in Adolescent Depression
- University of Utah, Salt Lake City
A’ fastadh
Aoisean 14 gu 17 · Gach gnè · Air ùrachadh 11 Lùna 2025 · NCT03859297Study of ALTO-300 in MDD
- Site 207, Clinton
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Iuch 2025 · NCT05922878Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.